Glucagon-like peptide-1 receptor agonists tied to higher thyroid cancer risk in first year of treatment
The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) ...
Inverse8h
Ozempic And Other GLP-1s Show Promise With 42 Conditions — But There Are Still Big Risks
Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...
Medscape19h
Is Motivational Interviewing Key to Sustaining Weight Loss?
They also don’t directly support behavior change, which Kathryn Ilonka Pollak, PhD, a professor in population health sciences ...
Josh Gad Lost 40 Lbs. Using Weight Loss Medication: 'I've Always Been the Funny Fat Guy. Can I Be the Funny Skinny Guy?'
Josh Gad says he's taking 'life-changing' GLP-1 medication for weight loss but admits that it can't replace having a healthy ...
Medscape18h
Empathy, Please: Be Sensitive Addressing Weight Management
Sometimes, the conversation doesn’t get past a handful of words, and just the attempt may threaten the patient-physician ...
HealthDay on MSN4h
GLP-1 RAs Tied to Higher Thyroid Cancer Risk in First Year of Treatment
THURSDAY, Jan. 30, 2025 (HealthDay News) -- The absolute risk for thyroid cancer is low among patients receiving ...
FDA approves Ozempic to help reduce risk of worsening chronic kidney disease
The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...
KSL4d
Study ties Ozempic-like drugs to dozens of benefits and risks
Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing ...